University Hospitals Medical Group
Welcome,         Profile    Billing    Logout  
 3 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Parikh, Sahil A
LIFE-BTK, NCT04227899: Randomized Controlled Trial

Active, not recruiting
N/A
261
US, RoW
Esprit BTK Device, Percutaneous Transluminal Angioplasty (PTA) Device
Abbott Medical Devices
Critical Limb Ischemia (CLI)
08/23
07/27
CHAMPIONSHIP, NCT06410313: First in Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients with Superficial Femoral Artery Disease And/or Proximal Popliteal Artery Disease

Recruiting
N/A
30
US, RoW
ChampioNIR Ridaforolimus Eluting Peripheral Stent System
Medinol Ltd.
Superficial Femoral Artery Stenosis, Popliteal Artery Stenosis
08/25
02/28
AcoArt BTK, NCT06330493: AcoArt Litos PCB Below-the-knee Global Trial

Recruiting
N/A
288
US
PCB, AcoArt Litos PCB, PTA
Acotec Scientific Co., Ltd
Chronic Limb-Threatening Ischemia
12/31
02/32
EspritBTKPAS, NCT06656364: Esprit BTK Post-Approval Study

Recruiting
N/A
200
US, RoW
Esprit BTK System
Abbott Medical Devices
Chronic Limb-Threatening Ischemia
04/27
05/29
DEEPER REVEAL, NCT05358353: A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System for the TREatment of Vascular Lesions Located in the InfrapoplitEal Arteries BeLow the Knee

Active, not recruiting
N/A
130
US
Bare Temporary Spur Stent System
ReFlow Medical, Inc.
Peripheral Arterial Disease, Critical Limb Ischemia
05/24
05/25
MAGICAL BTK, NCT06182397: Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in the Treatment of Below the Knee Arterial Disease

Not yet recruiting
N/A
368
NA
MagicTouch PTA Sirolimus drug coated balloon, Placebo balloon angioplasty
Concept Medical Inc.
Arterial Disease of Legs, Below-the-knee Obstruction, PAD - Peripheral Arterial Disease
12/26
02/31
ELEGANCE, NCT04674969: Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Recruiting
N/A
5000
Europe, Canada, US, RoW
Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
Boston Scientific Corporation
Peripheral Vascular Diseases
01/28
01/28
ELITE-BTK, NCT06071429: Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

Not yet recruiting
N/A
300
US
MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold, Percutaneous Transluminal Angioplasty (PTA)
R3 Vascular Inc.
Chronic Limb-Threatening Ischemia
03/28
03/32

Download Options